Literature DB >> 17021867

Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units?

E Meyer1, F Schwab, P Gastmeier, H Rüden, F D Daschner.   

Abstract

The study presented here was conducted over a period of 4 years (2001-2004) to investigate changes in the number of S. maltophilia isolates detected per 1,000 patient days and to look at the incidence density of nosocomial infections caused by S. maltophilia. The analysis was based on data provided by 34 German intensive care units participating continuously in the national project "Surveillance of Antimicrobial Use and Resistance in ICUs"; 31 of these ICUs reported nosocomial infections to the German infection surveillance system, KISS, during the study period.

Entities:  

Mesh:

Year:  2006        PMID: 17021867     DOI: 10.1007/s10096-006-0198-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center.

Authors:  V Krcméry; P Sykora; J Trupl; A Kunova; A Sabo; L Jurga; J Novotny; F Mateicka; R Babela; E Pichnova; I M Gould
Journal:  J Chemother       Date:  2001-04       Impact factor: 1.714

2.  Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI).

Authors:  E Meyer; D Jonas; F Schwab; H Rueden; P Gastmeier; F D Daschner
Journal:  Infection       Date:  2003-08       Impact factor: 3.553

Review 3.  Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.

Authors:  E Senol
Journal:  J Hosp Infect       Date:  2004-05       Impact factor: 3.926

4.  Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients.

Authors:  M E Villarino; L E Stevens; B Schable; G Mayers; J M Miller; J P Burke; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1992-04       Impact factor: 3.254

5.  Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.

Authors:  L S Elting; N Khardori; G P Bodey; V Fainstein
Journal:  Infect Control Hosp Epidemiol       Date:  1990-03       Impact factor: 3.254

6.  Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.

Authors:  D Gülmez; G Hasçelik
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

7.  The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen.

Authors:  S C Sanyal; E M Mokaddas
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

8.  Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System).

Authors:  Petra Gastmeier; Christine Geffers; Dorit Sohr; Markus Dettenkofer; Franz Daschner; Henning Rüden
Journal:  Am J Infect Control       Date:  2003-08       Impact factor: 2.918

9.  Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.

Authors:  L Calza; R Manfredi; F Chiodo
Journal:  Infection       Date:  2003-06       Impact factor: 3.553

10.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more
  1 in total

Review 1.  Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.

Authors:  Anthony A Adegoke; Thor A Stenström; Anthony I Okoh
Journal:  Front Microbiol       Date:  2017-11-30       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.